Lipid phosphate phosphatase-3 regulates tumor growth via β-catenin and Cyclin-D1 signaling

Molecular Cancer

Volumn 10, Issue , 2011, Pages

  Chatterjee, Ishita ^a   Humtsoe, Joseph O ^b   Kohler, Erin E ^a   Sorio, Claudio ^c   Wary, Kishore K ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF VERONA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CD133 ANTIGEN; CYCLIN D1; LIPID PHOSPHATE PHOSPHATASE 3; PHOSPHATASE; UNCLASSIFIED DRUG; LIPID PHOSPHATE PHOSPHATASE; PHOSPHATIDATE PHOSPHATASE;

ARTICLE; CARCINOGENICITY; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; GENE SILENCING; GLIOBLASTOMA; GROWTH REGULATION; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN STABILITY; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION; TUMOR CELL; TUMOR GROWTH; TUMOR XENOGRAFT; ANIMAL; CELL MOTION; CELL STRAIN HEK293; DRUG SCREENING; ENZYMOLOGY; FEMALE; GENETICS; METABOLISM; MOUSE; NEOPLASM; NUDE MOUSE; PATHOPHYSIOLOGY; TUMOR CELL LINE; TUMOR VOLUME;

ANIMALS; BETA CATENIN; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CYCLIN D1; FEMALE; GENE KNOCKDOWN TECHNIQUES; HEK293 CELLS; HUMANS; MICE; MICE, NUDE; NEOPLASMS; PHOSPHATIDATE PHOSPHATASE; SIGNAL TRANSDUCTION; TUMOR BURDEN; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 79955717052     PISSN: None     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-10-51     Document Type: Article

References (28)

1. Roberts R, Sciorra VA, Morris AJ. Human type 2 phosphatidic acid phosphohydrolases. Substrate specificity of the type 2a, 2b, and 2c enzymes and cell surface activity of the 2a isoform. J Biol Chem 1998, 273:22059-22067. 10.1074/jbc.273.34.22059, 9705349.
2. Alderton F, Darroch P, Sambi B, McKie A, Ahmed IS, Pyne N, Pyne S. G-protein-coupled receptor stimulation of the p42/p44 mitogen-activated protein kinase pathway is attenuated by lipid phosphate phosphatases 1, 1a and 2 in human embryonic kidney 293 cells. J Biol Chem 2001, 276:13452-13460. 10.1074/jbc.M006582200, 11278307.
3. Pyne S, Lee SC, Long J, Pyne NJ. Role of sphingosine kinases and lipid phosphate phosphatases in regulating spatial sphingosine 1-phosphate signalling in health and disease. Cell Signal 2009, 21:14-21. 10.1016/j.cellsig.2008.08.008, 18768158.
4. Brindley DN, Pilquil C. Lipid phosphate phosphatases and signaling. J Lipid Res 2009, 50(Suppl):S225-30. 2674702, 19066402.
5. Jia YJ, Kai M, Wada I, Sakane F, Kanoh H. Differential localization of lipid phosphate phosphatases 1 and 3 to cell surface subdomains in polarized MDCK cells. FEBS Lett 2003, 552:240-246. 10.1016/S0014-5793(03)00931-1, 14527693.
6. Sciorra VA, Morris AJ. Sequential actions of phospholipase D and phosphatidic acid phosphohydrolase 2b generate diglyceride in mammalian cells. Mol Biol Cell 1999, 10:3863-3876. 25685, 10564277.
7. Long JS, Pyne NJ, Pyne S. Lipid phosphate phosphatases form homo- and hetero-oligomers: catalytic competency, subcellular distribution and function. Biochem J 2008, 411:371-377. 10.1042/BJ20071607, 18215144.
8. Xu Y, Fang XJ, Casey G, Mills GB. Lysophospholipids activate ovarian and breast cancer cells. Biochem J 1995, 309(Pt 3):933-940. 1135721, 7639713.
9. Baker DL, Morrison P, Miller B, Riely CA, Tolley B, Westermann AM, Bonfrer JM, Bais E, Moolenaar WH, Tigyi G. Plasma lysophosphatidic acid concentration and ovarian cancer. JAMA 2002, 287:3081-3082. 10.1001/jama.287.23.3081, 12069669.
10. Kohno M, Momoi M, Oo ML, Paik JH, Lee YM, Venkataraman K, Ai Y, Ristimaki AP, Fyrst H, Sano H, Rosenberg D, Saba JD, Proia RL, Hla T. Intracellular role for sphingosine kinase 1 in intestinal adenoma cell proliferation. Mol Cell Biol 2006, 26:7211-7223. 10.1128/MCB.02341-05, 1592880, 16980623.
11. Tanyi JL, Hasegawa Y, Lapushin R, Morris AJ, Wolf JK, Berchuck A, Lu K, Smith DI, Kalli K, Hartmann LC, McCune K, Fishman D, Broaddus R, Cheng KW, Atkinson EN, Yamal JM, Bast RC, Felix EA, Newman RA, Mills GB. Role of decreased levels of lipid phosphate phosphatase-1 in accumulation of lysophosphatidic acid in ovarian cancer. Clin Cancer Res 2003, 9:3534-3545.
12. Tanyi JL, Morris AJ, Wolf JK, Fang X, Hasegawa Y, Lapushin R, Auersperg N, Sigal YJ, Newman RA, Felix EA, Atkinson EN, Mills GB. The human lipid phosphate phosphatase-3 decreases the growth, survival, and tumorigenesis of ovarian cancer cells: validation of the lysophosphatidic acid signaling cascade as a target for therapy in ovarian cancer. Cancer Res 2003, 63:1073-1082.
13. Wary KK, Thakker GD, Humtsoe JO, Yang J. Analysis of VEGF-responsive genes involved in the activation of endothelial cells. Mol Cancer 2003, 2:25. 10.1186/1476-4598-2-25, 179881, 12904264.
14. Humtsoe JO, Feng S, Thakker GD, Yang J, Hong J, Wary KK. Regulation of cell-cell interactions by phosphatidic acid phosphatase 2b/VCIP. EMBO J 2003, 22:1539-1554. 10.1093/emboj/cdg165, 152909, 12660161.
15. Humtsoe JO, Bowling RA, Feng S, Wary KK. Murine lipid phosphate phosphohydrolase-3 acts as a cell-associated integrin ligand. Biochem Biophys Res Commun 2005, 335:906-919. 10.1016/j.bbrc.2005.07.157, 16099422.
16. Wary KK, Humtsoe JO. Anti-lipid phosphate phosphohydrolase-3 (LPP3) antibody inhibits bFGF- and VEGF-induced capillary morphogenesis of endothelial cells. Cell Commun Signal 2005, 3:9. 10.1186/1478-811X-3-9, 1201157, 16076388.
17. Blais JD, Addison CL, Edge R, Falls T, Zhao H, Wary K, Koumenis C, Harding HP, Ron D, Holcik M, Bell JC. Perk-dependent translational regulation promotes tumor cell adaptation and angiogenesis in response to hypoxic stress. Mol Cell Biol 2006, 26:9517-9532. 10.1128/MCB.01145-06, 1698539, 17030613.
18. Humtsoe JO, Liu M, Malik AB, Wary KK. Lipid phosphate phosphatase 3 stabilization of beta-catenin induces endothelial cell migration and formation of branching point structures. Mol Cell Biol 2010, 30:1593-1606. 10.1128/MCB.00038-09, 2838065, 20123964.
19. Escalante-Alcalde D, Hernandez L, Le Stunff H, Maeda R, Lee HS, Gang-Cheng, Sciorra VA, Daar I, Spiegel S, Morris AJ, Stewart CL. The lipid phosphatase LPP3 regulates extra-embryonic vasculogenesis and axis patterning. Development 2003, 130:4623-4637. 10.1242/dev.00635, 12925589.
20. Nishisho I, Nakamura Y, Miyoshi Y, Miki Y, Ando H, Horii A, Koyama K, Utsunomiya J, Baba S, Hedge P. Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. Science 1991, 253:665-669. 10.1126/science.1651563, 1651563.
21. DeAngelis LM. Brain tumors. N Engl J Med 2001, 344:114-123. 10.1056/NEJM200101113440207, 11150363.
22. Friedman HS, Bigner DD. Glioblastoma multiforme and the epidermal growth factor receptor. N Engl J Med 2005, 353:1997-1999. 10.1056/NEJMp058186, 16282174.
23. Wurmser AE, Nakashima K, Summers RG, Toni N, D'Amour KA, Lie DC, Gage FH. Cell fusion-independent differentiation of neural stem cells to the endothelial lineage. Nature 2004, 430:350-356. 10.1038/nature02604, 15254537.
24. Ricci-Vitiani L, Pallini R, Biffoni M, Todaro M, Invernici G, Cenci T, Maira G, Parati EA, Stassi G, Larocca LM, De Maria R. Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells. Nature 2010, 468:824-828. 10.1038/nature09557, 21102434.
25. Wang R, Chadalavada K, Wilshire J, Kowalik U, Hovinga KE, Geber A, Fligelman B, Leversha M, Brennan C, Tabar V. Glioblastoma stem-like cells give rise to tumour endothelium. Nature 2010, 468:829-833. 10.1038/nature09624, 21102433.
26. Fischer I, Gagner JP, Law M, Newcomb EW, Zagzag D. Angiogenesis in gliomas: biology and molecular pathophysiology. Brain Pathol 2005, 15:297-310.
27. Cowan CE, Kohler EE, Dugan TA, Mirza MK, Malik AB, Wary KK. Kruppel-like factor-4 transcriptionally regulates VE-cadherin expression and endothelial barrier function. Circ Res 2010, 107:959-966. 10.1161/CIRCRESAHA.110.219592, 20724706.
28. Kohler EE, Cowan CE, Chatterjee I, Malik AB, Wary KK. NANOG induction of fetal liver kinase-1 (FLK1) transcription regulates endothelial cell proliferation and angiogenesis. Blood 2011, 117:1761-1769. 10.1182/blood-2010-07-295261, 21119109.